The Joint Corp. (JYNT) 10-Q 11 May 18 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 04, 2018
Document Information [Line Items]
Entity Registrant Name	JOINT Corp
Entity Central Index Key	1,612,630
Trading Symbol	jynt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		13,593,754
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 4,033,730	$ 4,216,221
Restricted cash	134,189	103,819
Accounts receivable, net	1,047,540	1,138,380
Notes receivable - current portion	176,262	171,928
Deferred franchise costs - current portion	522,123	498,433
Prepaid expenses and other current assets	733,502	542,342
Total current assets	6,647,346	6,671,123
Property and equipment, net	3,719,459	3,800,466
Notes receivable, net of current portion and reserve	306,132	351,857
Deferred franchise costs, net of current portion	2,422,698	2,312,837
Intangible assets, net	1,636,978	1,760,042
Goodwill	2,916,426	2,916,426
Deposits and other assets	594,213	611,808
Total assets	18,243,252	18,424,559
Current liabilities:
Accounts payable	935,658	1,068,668
Accrued expenses	197,812	86,959
Co-op funds liability	134,189	89,681
Payroll liabilities	846,919	867,430
Notes payable - current portion	100,000	100,000
Deferred rent - current portion	173,010	152,198
Deferred franchise revenue - current portion	1,986,524	1,994,182
Deferred revenue from company clinics	905,625	867,804
Other current liabilities	388,354	72,534
Total current liabilities	5,668,091	5,299,456
Notes payable, net of current portion	1,000,000	1,000,000
Deferred rent, net of current portion	750,010	802,492
Deferred franchise revenue, net of current portion	9,602,898	9,560,242
Deferred tax liability	57,191	136,434
Other liabilities	106,562	411,497
Total liabilities	17,184,752	17,210,121
Commitments and contingencies
Stockholders' equity:
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 shares issued and outstanding, as of March 31, 2018, and December 31, 2017
Common stock, $0.001 par value; 20,000,000 shares authorized, 13,607,838 shares issued and 13,593,754 shares outstanding as of March 31, 2018 and 13,600,338 shares issued and 13,586,254 outstanding as of December 31, 2017	13,607	13,600
Additional paid-in capital	37,460,828	37,229,869
Treasury stock 14,084 shares as of March 31, 2018 and December 31, 2017, at cost	(86,045)	(86,045)
Accumulated deficit	(36,329,890)	(35,942,986)
Total stockholders' equity	1,058,500	1,214,438
Total liabilities and stockholders' equity	$ 18,243,252	$ 18,424,559

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Series A preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series A preferred stock, shares authorized (in shares)	50,000	50,000
Series A preferred stock, shares issued (in shares)	0	0
Series A preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	13,607,838	13,600,338
Common stock, shares outstanding (in shares)	13,593,754	13,586,254
Treasury stock, shares (in shares)	14,084	14,084

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenues:
Revenue from Contract with Customer	$ 7,097,915	$ 5,507,147
Cost of revenues:
Total cost of revenues	972,332	693,716
Selling and marketing expenses	1,102,304	958,706
Depreciation and amortization	387,417	577,987
General and administrative expenses	5,074,927	4,564,078
Total selling, general and administrative expenses	6,564,648	6,100,771
Loss on disposition or impairment		417,971
Loss from operations	(439,065)	(1,705,311)
Other (expense) income, net	(11,194)	(19,465)
Loss before income tax benefit (expense)	(450,259)	(1,724,776)
Income tax benefit (expense)	63,355	(40,609)
Net loss and comprehensive loss	$ (386,904)	$ (1,765,385)
Loss per share:
Basic and diluted loss per share (in dollars per share)	$ (0.03)	$ (0.14)
Basic and diluted weighted average shares (in shares)	13,587,837	13,042,595
Revenues and Management Fees from Company Clinics [Member]
Revenues:
Revenue from Contract with Customer	$ 3,256,624	$ 2,496,334
Royalty [Member]
Revenues:
Revenue from Contract with Customer	2,273,988	1,706,073
Franchise [Member]
Revenues:
Revenue from Contract with Customer	348,337	295,540
Cost of revenues:
Cost of Goods and Services Sold	872,768	634,855
Advertising [Member]
Revenues:
Revenue from Contract with Customer	659,030	598,436
Technology Service [Member]
Revenues:
Revenue from Contract with Customer	307,475	267,013
Cost of revenues:
Cost of Goods and Services Sold	99,564	58,861
Regional Developer Fees [Member]
Revenues:
Revenue from Contract with Customer	135,011	64,146
Product and Service, Other [Member]
Revenues:
Revenue from Contract with Customer	$ 117,450	$ 79,605

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net loss	$ (386,904)	$ (1,765,385)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	387,417	577,987
Loss on sale of property and equipment	388
Loss on disposition or impairment of assets		417,971
Deferred income taxes	(79,243)	36,220
Stock based compensation expense	207,641	95,065
Changes in operating assets and liabilities:
Accounts receivable	90,840	(214,860)
Income taxes receivable		38,960
Prepaid expenses and other current assets	(191,160)	(393,995)
Deferred franchise costs	(133,551)	111,132
Deposits and other assets	17,595	40,868
Accounts payable	(133,010)	34,228
Accrued expenses	110,853	(138,455)
Co-op funds liability	44,508	21,761
Payroll liabilities	(20,511)	(353,326)
Other liabilities	10,885	101,014
Deferred rent	(31,670)	(309,367)
Deferred revenue	72,819	421,622
Net cash used in operating activities	(33,103)	(1,278,560)
Cash flows from investing activities:
Purchase of property and equipment	(183,734)	(39,325)
Payments received on notes receivable	41,391	10,008
Net cash used in investing activities	(142,343)	(29,317)
Cash flows from financing activities:
Borrowings on revolving credit note payable		1,000,000
Proceeds from exercise of stock options	23,325	116,277
Repayments on notes payable		(163,500)
Net cash provided by financing activities	23,325	952,777
Decrease in cash	(152,121)	(355,100)
Cash and restricted cash, beginning of period	4,320,040	3,344,258
Cash and restricted cash, end of period	$ 4,167,919	$ 2,989,158

Supplemental Disclosure of Non-

Supplemental Disclosure of Non-cash Activity	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Cash Flow, Supplemental Disclosures [Text Block]	During the three March 31, 2018 2017, $0 $5,875, three March 31, 2018 2017, $25,000 $30,161, Supplemental disclosure of non-cash activity: As of March 31, 2018 December 31, 2017, $0 $50,474,

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 1: Basis of Presentation These unaudited financial statements represent the condensed consolidated financial statements of The Joint Corp. (“The Joint”) and its wholly owned subsidiary The Joint Corporate Unit No. 1, 10 March 31, 2018 2017 not March 31, 2018 2017 The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses and other (expenses) income that are reported in the condensed consolidated financial statements and accompanying disclosures. These estimates are based on management’s best knowledge of current events, historical experience, actions that the Company may may 2, Revenue Disclosures March 31, 2017 Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Comprehensive Loss Net loss and comprehensive loss are the same for the three March 31, 2018 2017. Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three March 31, 2018 2017: Three Months Ended Franchised clinics: 2018 2017 Clinics in operation at beginning of period 352 309 Opened or Purchased during the period 7 18 Acquired during the period - - Closed during the period - (1 ) Clinics in operation at the end of the period 359 326 Three Months Ended Company-owned or managed clinics: 2018 2017 Clinics in operation at beginning of period 47 61 Opened during the period - - Acquired during the period - - Closed or sold during the period - (14 ) Clinics in operation at the end of the period 47 47 Total clinics in operation at the end of the period 406 373 Clinics licenses sold but not yet developed 114 107 Executed letters of intent for future clinic licenses 8 - Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not not Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not not Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no March 31, 2018 December 31, 2017. Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising. Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of March 31, 2018, one one 7% December 31, 2017, one six 13% not 10% three March 31, 2018 2017. Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees. The Company considers a reserve for doubtful accounts based on the creditworthiness of the entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of March 31, 2018 December 31, 2017, $0. Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally five Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions completed in the years ended December 31, 2014 December 31, 2016. not first fourth not No three March 31, 2018 2017. Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not not No three March 31, 2018 2017. Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2% Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets. Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change. Lease exit liability at December 31, 2017 $ 299,400 Additions - Settlements - Net accretion (12,171 ) Lease exit liability at March 31, 2018 $ 287,229 Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may Revenue Recognition The Company generates revenue primarily through its company-owned and managed clinics, royalties, franchise fees, advertising fund, and through IT related income and computer software fees. Revenues and Management Fees from Company Clinics. not Royalties and Advertising Fund Revenue. 7% 2% two Franchise Fees. ten no no Regional Developer Fees 2011, 2017, 3% Software Fees. Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $410,637 $286,415 three March 31, 2018 2017, Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not 50% not March 31, 2018 December 31, 2017. The Tax Cuts and Jobs Act of 2017 “2017 December 22, 2017. 2017 35% 21%, one not 2017 2017 March 31, 2018. 2017 may Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock and stock options. Three Months Ended 2018 2017 (as adjusted) Net loss $ (386,904 ) $ (1,765,385 ) Weighted average common shares outstanding - basic 13,587,837 13,042,595 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,587,837 13,042,595 Basic and diluted loss per share $ (0.03 ) $ (0.14 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended 2018 2017 Unvested restricted stock 63,700 80,070 Stock options 1,053,811 916,915 Warrants 90,000 90,000 Stock-Based Compensation The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations. Recent Accounting Pronouncements Accounting Standards Adopted Effective January 1, 2018 On January 1, 2018, 606 606” 606 not Adoption of ASC 606 THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS As of December 31, Adjustments due to ASC 606 adoption As of December 31, ASSETS (as reported) (as adjusted) Current assets: Deferred franchise costs - current portion $ 484 $ 14 $ 498 Total current assets 6,657 14 6,671 Deferred franchise costs, net of current portion 813 1,500 2,313 Total assets $ 16,910 $ 1,515 $ 18,425 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Deferred franchise revenue - current portion $ 1,686 $ 308 $ 1,994 Other current liabilities 49 24 73 Total current liabilities 4,967 332 5,299 Deferred revenue, net of current portion 4,693 4,867 9,560 Total liabilities 12,011 5,199 17,210 Stockholders' equity: Accumulated deficit (32,259 ) (3,684 ) (35,943 ) Total stockholders' equity 4,899 (3,684 ) 1,215 Total liabilities and stockholders' equity $ 16,910 $ 1,515 $ 18,425 The revenue and deferred cost adjustments are due to the change in method of recognizing franchise and regional developer fees. See Note 2, Revenue Disclosures Adoption of ASC 606 three March 31, 2017, THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended March 31, 2017 Adjustments due to ASC 606 adoption Three Months Ended March 31, 2017 (as reported) (as adjusted) Revenues: Franchise fees $ 450 $ (154 ) $ 296 Regional developer fees 77 (13 ) 64 Total revenues 5,674 (167 ) 5,507 Cost of revenues: Franchise cost of revenues 683 (48 ) 635 Total cost of revenues 742 (48 ) 694 Loss from operations (1,587 ) (118 ) (1,705 ) Loss before income tax expense (1,606 ) (118 ) (1,725 ) Net loss and comprehensive loss $ (1,647 ) $ (118 ) $ (1,765 ) Loss per share: Basic and diluted loss per share $ (0.13 ) $ (0.01 ) $ (0.14 ) The revenue and deferred cost adjustments are due to the change in method of recognizing franchise and regional developer fees. See Note 2, Revenue Disclosures In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 January 1, 2018 $21,843 March 31, 2017, three March 31, 2017. 1. Restricted Cash’ Additional new accounting guidance became effective for the Company effective January 1, 2018 not no Newly Issued Accounting Standards Not In February 2016, No. 2016 02, Leases (Topic 842 12 first 2019. While the Company is still in the process of evaluating the impact of the new guidance on its consolidated financial statements and disclosures, the Company expects adoption of the new guidance will have a material impact on its Consolidated Balance Sheets due to recognition of the right-of-use asset and lease liability related to its operating leases. While the new guidance is also expected to impact the measurement and presentation of elements of expenses and cash flows related to leasing arrangements, the Company does not not The Company reviewed other newly issued accounting pronouncements and concluded that they either are not no

Note 2 - Revenue Disclosures

Note 2 - Revenue Disclosures	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 2: Company-owned or Managed Clinics The Company earns revenues from clinics that it owns and operates or manages throughout the United States. In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor’s PC. Under the management agreement, the Company provides administrative and business management services to the doctor’s PC in return for a monthly management fee. Due to certain implicit variable consideration in these management agreement contracts, and based on past practices between the parties, the Company determined that it cannot meet the probable threshold if it includes all of the variable consideration in the transaction price. Therefore, the Company recognizes revenue under these contracts only when it has a high degree of confidence that revenue will not Franchising Fees, Royalty Fees, Advertising Fund Revenue, and Software Fees The Company currently franchises its concept across 29 not not The transaction price in a standard franchise arrangement primarily consists of (a) initial franchise fees; (b) continuing franchise fees (royalties); (c) advertising fees; and (d) software fees. Since the Company considers the licensing of the franchising right to be a single performance obligation, no The Company recognizes the primary components of the transaction price as follows: • Franchise fees are recognized as revenue ratably on a straight-line basis over the term of the franchise agreement commencing with the execution of the franchise agreement. As these fees are typically received in cash at or near the beginning of the franchise term, the cash received is initially recorded as a contract liability until recognized as revenue over time; • The Company is entitled to royalties and advertising fees based on a percentage of the franchisee's gross sales as defined in the franchise agreement. Royalty and advertising revenue is recognized when the franchisee's sales occur. Depending on timing within a fiscal period, the recognition of revenue results in either what is considered a contract asset (unbilled receivable) or, once billed, accounts receivable, on the balance sheet. • The Company is entitled to a monthly software fee, which is charged monthly. The Company recognizes revenue related to these software fees ratably on a straight-line basis over the term of the franchise agreement. In determining the amount and timing of revenue from contracts with customers, the Company exercises significant judgment with respect to collectability of the amount; however, the timing of recognition does not none not Prior to the adoption of ASC 606, 1, Nature of Operations and Summary of Significant Accounting Policies Under ASC 606, 606 may not Regional Developer Fees The Company currently utilizes eighteen not not The transaction price in a standard regional developer arrangement primarily consists of the initial territory fees. The Company recognizes the regional developer fee as revenue ratably on a straight-line basis over the term of the regional developer agreement commencing with the execution of the regional developer agreement. As these fees are typically received in cash at or near the beginning of the term of the regional developer agreement, the cash received is initially recorded as a contract liability until recognized as revenue over time. Disaggregation of Revenue The Company believes that the captions contained on the condensed consolidated statements of operations appropriately reflect the disaggregation of its revenue by major type for the three March 31, 2018 2017. Rollforward of Contract Liabilities and Contract Assets Changes in the Company's contract liability for deferred franchise and regional development fees during the three March 31, 2018 Deferred Revenue Balance at December 31, 2017 $ 11,554 Recognized as revenue during the three months ended March 31, 2018 (483 ) Fees received and deferred during the three months ended March 31, 2018 518 Balance at March 31, 2018 $ 11,589 Changes in the Company's contract assets for deferred franchise costs during the three March 31, 2018 Deferred Balance at December 31, 2017 $ 2,811 Recognized as cost of revenue during the three months ended March 31, 2018 (126 ) Costs incurred and deferred during the three months ended March 31, 2018 260 Balance at March 31, 2018 $ 2,945 The following table illustrates estimated revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of March 31, 2018 Contract liabilities expected to be recognized in Amount 2018 (remaining) $ 1,497 2019 1,987 2020 1,988 2021 1,863 2022 1,432 Thereafter 2,822 Total $ 11,589

Note 3 - Restricted Cash

Note 3 - Restricted Cash	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Restricted Cash [Text Block]	Note 3. The table below reconciles the cash and cash equivalents balance and restricted cash balances from our condensed consolidated balance sheet to the amount of cash reported on the condensed consolidated statement of cash flows: March 31, March 31, Cash and cash equivalents $ 4,033,730 $ 2,676,607 Restricted cash 134,189 312,551 Total cash, cash equivalents and restricted cash $ 4,167,919 $ 2,989,158

Note 4 - Notes Receivable

Note 4 - Notes Receivable	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 4: Effective April 29, 2017, $320,000, $187,000 10% 42 36 November 1, 2017 October 1, 2020. Effective August 31, 2017, $220,000, $117,475 10% 36 36 September 1, 2017 August 1, 2020. Effective September 22, 2017, $228,293, $119,147 10% 36 36 October 1, 2017 September 1, 2020. Effective October 10, 2017, $170,000, $135,688 10% 36 36 September 24, 2017 October 24, 2020. The net outstanding balances of the notes as of March 31, 2018 December 31, 2017 $482,395 $523,785,

Note 5 - Property and Equipment

Note 5 - Property and Equipment	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 5: Property and equipment consists of the following: March 31, December 31, Office and computer equipment $ 1,170,334 $ 1,137,970 Leasehold improvements 5,162,883 5,117,379 Software developed 1,147,594 1,066,454 7,480,811 7,321,803 Accumulated depreciation (4,192,702 ) (3,928,349 ) 3,288,109 3,393,454 Construction in progress 431,350 407,012 $ 3,719,459 $ 3,800,466 Depreciation expense was $264,353 $403,131 three March 31, 2018 2017

Note 6 - Fair Value Considerati

Note 6 - Fair Value Consideration	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 6: The Company’s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities. The Company does not Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no As of March 31, 2018 December 31, 2017, not 1, 2 3.

Note 7 - Intangible Assets

Note 7 - Intangible Assets	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 7: Intangible assets consist of the following: As of March 31, 2018 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 719,757 $ 953,243 Customer relationships 701,000 694,417 6,583 Reacquired development rights 1,162,000 484,848 677,152 $ 3,536,000 $ 1,899,022 $ 1,636,978 As of December 31, 2017 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 657,943 $ 1,015,057 Customer relationships 701,000 674,667 26,333 Reacquired development rights 1,162,000 443,348 718,652 $ 3,536,000 $ 1,775,958 $ 1,760,042 Amortization expense was $123,064 $174,856 three March 31, 2018 2017, Estimated amortization expense for 2018 2018 (remainder) $ 316,525 2019 413,256 2020 413,256 2021 348,034 2022 133,693 Thereafter 12,214 Total $ 1,636,978

Note 8 - Debt

Note 8 - Debt	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 8: Notes Payable During 2015, 12 February 2017, $800,350 1.5% 5.25%. During 2016, two $186,000 4.25% May 2017. one Maturities of notes payable are as follows as of March 31, 2018: 2018 (remainder) $ 100,000 Total $ 100,000 Credit and Security Agreement On January 3, 2017, $5,000,000 10% $200,000. not $25,000. December 2019, March 31, 2018, $1,000,000 $5,000,000

Note 9 - Equity

Note 9 - Equity	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 9: Stock Options In the three March 31, 2018, 60,000 $4.92 $6.85. Upon the completion of the Company’s IPO in November 2014, 10 The Company has computed the fair value of all options granted during the three March 31, 2018 2017, Three Months Ended March 31, 2018 2017 Expected volatility 42% - 43% 42% Expected dividends None None Expected term (years) 7 7 Risk-free rate 2.53% to 2.63% 2.10% to 2.14% Forfeiture rate 20 % 20% The information below summarizes the stock options activity: Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 295,286 4.31 Exercised (206,875 ) 1.76 Cancelled (37,570 ) 5.11 Outstanding at December 31, 2017 1,003,916 $ 4.18 $ 1.87 8.1 Granted at market price 60,000 5.89 Exercised (7,500 ) 3.11 Cancelled (2,605 ) 5.03 Outstanding at March 31, 2018 1,053,811 $ 4.29 $ 1.93 8.0 Exercisable at March 31, 2018 476,601 $ 4.77 $ 2.07 7.6 The intrinsic value of the Company’s stock options outstanding was $2,885,475 March 31, 2018. For the three March 31, 2018 2017, $139,172 $51,038, March 31, 2018 $867,997, 2.9 Restricted Stock The information below summaries the restricted stock activity: Restricted Stock Awards Shares Outstanding at December 31, 2017 63,700 Awards granted - Awards vested - Awards forfeited - Outstanding at March 31, 2018 63,700 For the three March 31, 2018 2017, $68,469 $44,027, March 31, 2018 $74,772, June 1, 2018.

Note 10 - Income Taxes

Note 10 - Income Taxes	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 10: During the three March 31, 2018 2017, $63,000 $41,000,

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 11: The Company entered into consulting and legal agreements with certain common stockholders related to services performed for the operations and transaction related activities of the Company. Amounts paid to or for the benefit of these stockholders was approximately $48,000 $52,000 three March 31, 2018 2017,

Note 12 - Commitments and Conti

Note 12 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 12: Operating Leases The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio. Total rent expense for the three March 31, 2018 2017 $685,677 $744,295, Future minimum annual lease payments are as follows: 2018 (remainder) $ 1,904,467 2019 2,354,982 2020 2,105,402 2021 1,991,650 2022 1,879,686 Thereafter 3,253,292 Total $ 13,489,479

Note 13 - Segment Reporting

Note 13 - Segment Reporting	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 13: An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (“CODM”) to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer. The Company has two March 31, 2018, 47 March 31, 2018, 359 two The tables below present financial information for the Company’s two Three Months Ended 2018 2017 Revenues: (as adjusted) Corporate clinics $ 3,257 $ 2,497 Franchise operations 3,841 3,010 Total revenues $ 7,098 $ 5,507 Segment operating (loss) income: Corporate clinics $ 111 $ (1,017 ) Franchise operations 1,815 1,233 Total segment operating (loss) income $ 1,926 $ 216 Depreciation and amortization: Corporate clinics $ 303 $ 444 Franchise operations - - Corporate administration 84 134 Total depreciation and amortization $ 387 $ 578 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes (in thousands): Total segment operating (loss) income $ 1,926 $ 216 Unallocated corporate (2,365 ) (1,921 ) Consolidated loss from operations (439 ) (1,705 ) Other (expense) income, net (11 ) (19 ) Loss before income tax expense $ (450 ) $ (1,725 ) March 31, December 31, Segment assets: ( as adjusted) Corporate clinics $ 8,695 $ 8,998 Franchise operations 3,938 3,876 Total segment assets $ 12,633 $ 12,874 Unallocated cash and cash equivalents and restricted cash $ 4,168 $ 4,320 Unallocated property and equipment 777 765 Other unallocated assets 665 466 Total assets $ 18,243 $ 18,425 “Unallocated cash and cash equivalents and restricted cash” relates primarily to corporate cash and cash equivalents and restricted cash (see Note 1

Note 14 - Subsequent Events

Note 14 - Subsequent Events	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Subsequent Events [Text Block]	Note 14: On April 6, 2018, one second $100,000.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2018
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Loss Net loss and comprehensive loss are the same for the three March 31, 2018 2017.
Nature of Operations Policy [Policy Text Block]	Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three March 31, 2018 2017: Three Months Ended Franchised clinics: 2018 2017 Clinics in operation at beginning of period 352 309 Opened or Purchased during the period 7 18 Acquired during the period - - Closed during the period - (1 ) Clinics in operation at the end of the period 359 326 Three Months Ended Company-owned or managed clinics: 2018 2017 Clinics in operation at beginning of period 47 61 Opened during the period - - Acquired during the period - - Closed or sold during the period - (14 ) Clinics in operation at the end of the period 47 47 Total clinics in operation at the end of the period 406 373 Clinics licenses sold but not yet developed 114 107 Executed letters of intent for future clinic licenses 8 -
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not not Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not not
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no March 31, 2018 December 31, 2017.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of March 31, 2018, one one 7% December 31, 2017, one six 13% not 10% three March 31, 2018 2017.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees. The Company considers a reserve for doubtful accounts based on the creditworthiness of the entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of March 31, 2018 December 31, 2017, $0.
Revenue Recognition, Services, Commissions [Policy Text Block]	Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally over the term of the related franchise agreement.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.
Internal Use Software, Policy [Policy Text Block]	Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally five
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions completed in the years ended December 31, 2014 December 31, 2016. not first fourth not No three March 31, 2018 2017.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not not No three March 31, 2018 2017.
Advertising Fund, Policy [Policy Text Block]	Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2%
Cooperative Advertising Policy [Policy Text Block]	Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets.
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]	Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change. Lease exit liability at December 31, 2017 $ 299,400 Additions - Settlements - Net accretion (12,171 ) Lease exit liability at March 31, 2018 $ 287,229
Lessee, Leases [Policy Text Block]	Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company generates revenue primarily through its company-owned and managed clinics, royalties, franchise fees, advertising fund, and through IT related income and computer software fees.
Revenues and Management Fees, Policy [Policy Text Block]	Revenues and Management Fees from Company Clinics. not
Royalties, Policy [Policy Text Block]	Royalties and Advertising Fund Revenue. 7% 2% two
Revenue Recognition, Services, Franchise Fees [Policy Text Block]	Franchise Fees. ten no no
Regional Developer Fees, Policy [Policy Text Block]	Regional Developer Fees 2011, 2017, 3%
IT Related Income And Software Fees, Policy [Policy Text Block]	Software Fees.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $410,637 $286,415 three March 31, 2018 2017,
Income Tax, Policy [Policy Text Block]	Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not 50% not March 31, 2018 December 31, 2017. The Tax Cuts and Jobs Act of 2017 “2017 December 22, 2017. 2017 35% 21%, one not 2017 2017 March 31, 2018. 2017 may
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock and stock options. Three Months Ended 2018 2017 (as adjusted) Net loss $ (386,904 ) $ (1,765,385 ) Weighted average common shares outstanding - basic 13,587,837 13,042,595 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,587,837 13,042,595 Basic and diluted loss per share $ (0.03 ) $ (0.14 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended 2018 2017 Unvested restricted stock 63,700 80,070 Stock options 1,053,811 916,915 Warrants 90,000 90,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements Accounting Standards Adopted Effective January 1, 2018 On January 1, 2018, 606 606” 606 not Adoption of ASC 606 THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS As of December 31, Adjustments due to ASC 606 adoption As of December 31, ASSETS (as reported) (as adjusted) Current assets: Deferred franchise costs - current portion $ 484 $ 14 $ 498 Total current assets 6,657 14 6,671 Deferred franchise costs, net of current portion 813 1,500 2,313 Total assets $ 16,910 $ 1,515 $ 18,425 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Deferred franchise revenue - current portion $ 1,686 $ 308 $ 1,994 Other current liabilities 49 24 73 Total current liabilities 4,967 332 5,299 Deferred revenue, net of current portion 4,693 4,867 9,560 Total liabilities 12,011 5,199 17,210 Stockholders' equity: Accumulated deficit (32,259 ) (3,684 ) (35,943 ) Total stockholders' equity 4,899 (3,684 ) 1,215 Total liabilities and stockholders' equity $ 16,910 $ 1,515 $ 18,425 The revenue and deferred cost adjustments are due to the change in method of recognizing franchise and regional developer fees. See Note 2, Revenue Disclosures Adoption of ASC 606 three March 31, 2017, THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended March 31, 2017 Adjustments due to ASC 606 adoption Three Months Ended March 31, 2017 (as reported) (as adjusted) Revenues: Franchise fees $ 450 $ (154 ) $ 296 Regional developer fees 77 (13 ) 64 Total revenues 5,674 (167 ) 5,507 Cost of revenues: Franchise cost of revenues 683 (48 ) 635 Total cost of revenues 742 (48 ) 694 Loss from operations (1,587 ) (118 ) (1,705 ) Loss before income tax expense (1,606 ) (118 ) (1,725 ) Net loss and comprehensive loss $ (1,647 ) $ (118 ) $ (1,765 ) Loss per share: Basic and diluted loss per share $ (0.13 ) $ (0.01 ) $ (0.14 ) The revenue and deferred cost adjustments are due to the change in method of recognizing franchise and regional developer fees. See Note 2, Revenue Disclosures In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 January 1, 2018 $21,843 March 31, 2017, three March 31, 2017. 1. Restricted Cash’ Additional new accounting guidance became effective for the Company effective January 1, 2018 not no Newly Issued Accounting Standards Not In February 2016, No. 2016 02, Leases (Topic 842 12 first 2019. While the Company is still in the process of evaluating the impact of the new guidance on its consolidated financial statements and disclosures, the Company expects adoption of the new guidance will have a material impact on its Consolidated Balance Sheets due to recognition of the right-of-use asset and lease liability related to its operating leases. While the new guidance is also expected to impact the measurement and presentation of elements of expenses and cash flows related to leasing arrangements, the Company does not not The Company reviewed other newly issued accounting pronouncements and concluded that they either are not no

Note 1 - Nature of Operations22

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Franchisor Disclosure [Table Text Block]	Three Months Ended Franchised clinics: 2018 2017 Clinics in operation at beginning of period 352 309 Opened or Purchased during the period 7 18 Acquired during the period - - Closed during the period - (1 ) Clinics in operation at the end of the period 359 326 Three Months Ended Company-owned or managed clinics: 2018 2017 Clinics in operation at beginning of period 47 61 Opened during the period - - Acquired during the period - - Closed or sold during the period - (14 ) Clinics in operation at the end of the period 47 47 Total clinics in operation at the end of the period 406 373 Clinics licenses sold but not yet developed 114 107 Executed letters of intent for future clinic licenses 8 -
Lease Exit Liability [Table Text Block]	Lease exit liability at December 31, 2017 $ 299,400 Additions - Settlements - Net accretion (12,171 ) Lease exit liability at March 31, 2018 $ 287,229
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended 2018 2017 (as adjusted) Net loss $ (386,904 ) $ (1,765,385 ) Weighted average common shares outstanding - basic 13,587,837 13,042,595 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,587,837 13,042,595 Basic and diluted loss per share $ (0.03 ) $ (0.14 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended 2018 2017 Unvested restricted stock 63,700 80,070 Stock options 1,053,811 916,915 Warrants 90,000 90,000
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS As of December 31, Adjustments due to ASC 606 adoption As of December 31, ASSETS (as reported) (as adjusted) Current assets: Deferred franchise costs - current portion $ 484 $ 14 $ 498 Total current assets 6,657 14 6,671 Deferred franchise costs, net of current portion 813 1,500 2,313 Total assets $ 16,910 $ 1,515 $ 18,425 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Deferred franchise revenue - current portion $ 1,686 $ 308 $ 1,994 Other current liabilities 49 24 73 Total current liabilities 4,967 332 5,299 Deferred revenue, net of current portion 4,693 4,867 9,560 Total liabilities 12,011 5,199 17,210 Stockholders' equity: Accumulated deficit (32,259 ) (3,684 ) (35,943 ) Total stockholders' equity 4,899 (3,684 ) 1,215 Total liabilities and stockholders' equity $ 16,910 $ 1,515 $ 18,425 THE JOINT CORP. AND SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended March 31, 2017 Adjustments due to ASC 606 adoption Three Months Ended March 31, 2017 (as reported) (as adjusted) Revenues: Franchise fees $ 450 $ (154 ) $ 296 Regional developer fees 77 (13 ) 64 Total revenues 5,674 (167 ) 5,507 Cost of revenues: Franchise cost of revenues 683 (48 ) 635 Total cost of revenues 742 (48 ) 694 Loss from operations (1,587 ) (118 ) (1,705 ) Loss before income tax expense (1,606 ) (118 ) (1,725 ) Net loss and comprehensive loss $ (1,647 ) $ (118 ) $ (1,765 ) Loss per share: Basic and diluted loss per share $ (0.13 ) $ (0.01 ) $ (0.14 )

Note 2 - Revenue Disclosures (T

Note 2 - Revenue Disclosures (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Contract with Customer, Asset and Liability [Table Text Block]	Deferred Revenue Balance at December 31, 2017 $ 11,554 Recognized as revenue during the three months ended March 31, 2018 (483 ) Fees received and deferred during the three months ended March 31, 2018 518 Balance at March 31, 2018 $ 11,589 Deferred Balance at December 31, 2017 $ 2,811 Recognized as cost of revenue during the three months ended March 31, 2018 (126 ) Costs incurred and deferred during the three months ended March 31, 2018 260 Balance at March 31, 2018 $ 2,945
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	Contract liabilities expected to be recognized in Amount 2018 (remaining) $ 1,497 2019 1,987 2020 1,988 2021 1,863 2022 1,432 Thereafter 2,822 Total $ 11,589

Note 3 - Restricted Cash (Table

Note 3 - Restricted Cash (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Reconciliation of Cash, Cash Equivalents and Restricted Cash Balance [Table Text Block]	March 31, March 31, Cash and cash equivalents $ 4,033,730 $ 2,676,607 Restricted cash 134,189 312,551 Total cash, cash equivalents and restricted cash $ 4,167,919 $ 2,989,158

Note 5 - Property and Equipme25

Note 5 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, December 31, Office and computer equipment $ 1,170,334 $ 1,137,970 Leasehold improvements 5,162,883 5,117,379 Software developed 1,147,594 1,066,454 7,480,811 7,321,803 Accumulated depreciation (4,192,702 ) (3,928,349 ) 3,288,109 3,393,454 Construction in progress 431,350 407,012 $ 3,719,459 $ 3,800,466

Note 7 - Intangible Assets (Tab

Note 7 - Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	As of March 31, 2018 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 719,757 $ 953,243 Customer relationships 701,000 694,417 6,583 Reacquired development rights 1,162,000 484,848 677,152 $ 3,536,000 $ 1,899,022 $ 1,636,978 As of December 31, 2017 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 657,943 $ 1,015,057 Customer relationships 701,000 674,667 26,333 Reacquired development rights 1,162,000 443,348 718,652 $ 3,536,000 $ 1,775,958 $ 1,760,042
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2018 (remainder) $ 316,525 2019 413,256 2020 413,256 2021 348,034 2022 133,693 Thereafter 12,214 Total $ 1,636,978

Note 8 - Debt (Tables)

Note 8 - Debt (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	2018 (remainder) $ 100,000 Total $ 100,000

Note 9 - Equity (Tables)

Note 9 - Equity (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended March 31, 2018 2017 Expected volatility 42% - 43% 42% Expected dividends None None Expected term (years) 7 7 Risk-free rate 2.53% to 2.63% 2.10% to 2.14% Forfeiture rate 20 % 20%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 295,286 4.31 Exercised (206,875 ) 1.76 Cancelled (37,570 ) 5.11 Outstanding at December 31, 2017 1,003,916 $ 4.18 $ 1.87 8.1 Granted at market price 60,000 5.89 Exercised (7,500 ) 3.11 Cancelled (2,605 ) 5.03 Outstanding at March 31, 2018 1,053,811 $ 4.29 $ 1.93 8.0 Exercisable at March 31, 2018 476,601 $ 4.77 $ 2.07 7.6
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	Restricted Stock Awards Shares Outstanding at December 31, 2017 63,700 Awards granted - Awards vested - Awards forfeited - Outstanding at March 31, 2018 63,700

Note 12 - Commitments and Con29

Note 12 - Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2018 (remainder) $ 1,904,467 2019 2,354,982 2020 2,105,402 2021 1,991,650 2022 1,879,686 Thereafter 3,253,292 Total $ 13,489,479

Note 13 - Segment Reporting (Ta

Note 13 - Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended 2018 2017 Revenues: (as adjusted) Corporate clinics $ 3,257 $ 2,497 Franchise operations 3,841 3,010 Total revenues $ 7,098 $ 5,507 Segment operating (loss) income: Corporate clinics $ 111 $ (1,017 ) Franchise operations 1,815 1,233 Total segment operating (loss) income $ 1,926 $ 216 Depreciation and amortization: Corporate clinics $ 303 $ 444 Franchise operations - - Corporate administration 84 134 Total depreciation and amortization $ 387 $ 578 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes (in thousands): Total segment operating (loss) income $ 1,926 $ 216 Unallocated corporate (2,365 ) (1,921 ) Consolidated loss from operations (439 ) (1,705 ) Other (expense) income, net (11 ) (19 ) Loss before income tax expense $ (450 ) $ (1,725 )
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	March 31, December 31, Segment assets: ( as adjusted) Corporate clinics $ 8,695 $ 8,998 Franchise operations 3,938 3,876 Total segment assets $ 12,633 $ 12,874 Unallocated cash and cash equivalents and restricted cash $ 4,168 $ 4,320 Unallocated property and equipment 777 765 Other unallocated assets 665 466 Total assets $ 18,243 $ 18,425

Supplemental Disclosure of No31

Supplemental Disclosure of Non-cash Activity (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Income Taxes Paid	$ 0	$ 5,875
Interest Paid, Excluding Capitalized Interest, Operating Activities	25,000	$ 30,161
Capital Expenditures Incurred but Not yet Paid	$ 0		$ 50,474

Note 1 - Nature of Operations32

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2018USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018	Dec. 31, 2017USD ($)
Cash Equivalents, at Carrying Value, Total	$ 0			$ 0
Allowance for Doubtful Accounts Receivable, Ending Balance	0			$ 0
Impairment of Intangible Assets, Finite-lived	0
Goodwill, Impairment Loss	0	$ 0
Impairment of Long-Lived Assets Held-for-use	$ 0	0
Franchise Monthly Marketing Fee Gross Sales Percentage	2.00%
Franchise Royalty Gross Sales Percentage	7.00%
Regional Developers Royalty Sales Generated by Franchises Percentage	3.00%
Advertising Expense	$ 410,637	$ 286,415
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent				35.00%
The Three Months Ended March, 31 2017 [Member] | Reclassification of Restricted Cash in to Cash, Cash Equivalents and Restricted Cash [Member]
Prior Period Reclassification Adjustment	$ 21,843
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			21.00%
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	5 years
Development Rights [Member]
Finite-Lived Intangible Asset, Useful Life	7 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life	2 years
Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Minimum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life	6 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	7 years
Maximum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life	8 years
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Number of PC Entities	1			1
Number of Franchises	1			6
Concentration Risk, Percentage				13.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Number of Major Customers	0	0

Note 1 - Nature of Operations33

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Clinics in operation at beginning of period	47	61
Clinics in operation at the end of the period	406	373
Number of Stores	47	61	406	373
Clinics licenses sold but not yet developed			114	107
Executed letters of intent for future clinic licenses			8
Franchised Units [Member]
Clinics in operation at beginning of period	352	309
Opened or Purchased during the period	7	18
Acquired during the period
Closed during the period		(1)
Clinics in operation at the end of the period	359	326
Number of Stores	352	309	359	326
Entity Operated Units [Member]
Opened or Purchased during the period
Acquired during the period
Closed during the period		(14)
Clinics in operation at the end of the period	47	47
Number of Stores	47	47	47	47

Note 1 - Nature of Operations34

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Lease Exit Liability (Details)	3 Months Ended
	Mar. 31, 2018USD ($)
Lease exit liability at December 31, 2017	$ 299,400
Additions
Settlements
Net accretion	(12,171)
Lease exit liability at March 31, 2018	$ 287,229

Note 1 - Nature of Operations35

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Net loss	$ (386,904)	$ (1,765,385)
Weighted average common shares outstanding - basic (in shares)	13,587,837	13,042,595
Effect of dilutive securities:
Stock options (in shares)
Weighted average common shares outstanding - diluted (in shares)	13,587,837	13,042,595
Basic and diluted loss per share (in dollars per share)	$ (0.03)	$ (0.14)

Note 1 - Nature of Operations36

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Restricted Stock [Member]
Anti-dilutive Securities (in shares)	63,700	80,070
Employee Stock Option [Member]
Anti-dilutive Securities (in shares)	1,053,811	916,915
Warrant [Member]
Anti-dilutive Securities (in shares)	90,000	90,000

Note 1 - Nature of Operations37

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Impact of New Standard on Previously Reported Balance Sheet and Income Statement (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Current assets:
Deferred franchise costs - current portion			$ 498,000
Total current assets	$ 6,647,346		6,671,123
Deferred franchise costs, net of current portion			2,313,000
Total assets	18,243,252		18,424,559
Current liabilities:
Deferred franchise revenue - current portion			1,994,000
Other current liabilities	388,354		72,534
Total current liabilities	5,668,091		5,299,456
Deferred revenue, net of current portion			9,560,000
Total liabilities	17,184,752		17,210,121
Stockholders' equity:
Accumulated deficit	(36,329,890)		(35,942,986)
Total stockholders' equity	1,058,500		1,214,438
Total liabilities and stockholders' equity	18,243,252		18,424,559
Revenues:
Revenue from Contract with Customer	7,097,915	$ 5,507,147
Cost of revenues:
Total cost of revenues	972,332	693,716
Operating income (loss)	(439,065)	(1,705,311)
Loss before income tax expense	(450,259)	(1,724,776)
Net loss	$ (386,904)	$ (1,765,385)
Loss per share:
Basic and diluted loss per share (in dollars per share)	$ (0.03)	$ (0.14)
Franchise [Member]
Revenues:
Revenue from Contract with Customer	$ 348,337	$ 295,540
Cost of revenues:
Franchise cost of revenues	872,768	634,855
Regional Developer Fees [Member]
Revenues:
Revenue from Contract with Customer	$ 135,011	64,146
Previously Reported [Member]
Current assets:
Deferred franchise costs - current portion			484,000
Total current assets			6,657,000
Deferred franchise costs, net of current portion			813,000
Total assets			16,910,000
Current liabilities:
Deferred franchise revenue - current portion			1,686,000
Other current liabilities			49,000
Total current liabilities			4,967,000
Deferred revenue, net of current portion			4,693,000
Total liabilities			12,011,000
Stockholders' equity:
Accumulated deficit			(32,259,000)
Total stockholders' equity			4,899,000
Total liabilities and stockholders' equity			16,910,000
Revenues:
Revenue from Contract with Customer		5,674,000
Cost of revenues:
Total cost of revenues		742,000
Operating income (loss)		(1,587,000)
Loss before income tax expense		(1,606,000)
Net loss		$ (1,647,000)
Loss per share:
Basic and diluted loss per share (in dollars per share)		$ (0.13)
Previously Reported [Member] | Franchise [Member]
Revenues:
Revenue from Contract with Customer		$ 450,000
Cost of revenues:
Franchise cost of revenues		683,000
Previously Reported [Member] | Regional Developer Fees [Member]
Revenues:
Revenue from Contract with Customer		77,000
Restatement Adjustment [Member] | Accounting Standards Update 2014-09 [Member]
Current assets:
Deferred franchise costs - current portion			14,000
Total current assets			14,000
Deferred franchise costs, net of current portion			1,500,000
Total assets			1,515,000
Current liabilities:
Deferred franchise revenue - current portion			308,000
Other current liabilities			24,000
Total current liabilities			332,000
Deferred revenue, net of current portion			4,867,000
Total liabilities			5,199,000
Stockholders' equity:
Accumulated deficit			(3,684,000)
Total stockholders' equity			(3,684,000)
Total liabilities and stockholders' equity			$ 1,515,000
Revenues:
Revenue from Contract with Customer		(167,000)
Cost of revenues:
Total cost of revenues		(48,000)
Operating income (loss)		(118,000)
Loss before income tax expense		(118,000)
Net loss		$ (118,000)
Loss per share:
Basic and diluted loss per share (in dollars per share)		$ (0.01)
Restatement Adjustment [Member] | Franchise [Member] | Accounting Standards Update 2014-09 [Member]
Revenues:
Revenue from Contract with Customer		$ (154,000)
Cost of revenues:
Franchise cost of revenues		(48,000)
Restatement Adjustment [Member] | Regional Developer Fees [Member] | Accounting Standards Update 2014-09 [Member]
Revenues:
Revenue from Contract with Customer		$ (13,000)

Note 2 - Revenue Disclosures (D

Note 2 - Revenue Disclosures (Details Textual)	Mar. 31, 2018
Number of States in which Entity Franchises	29

Note 2 - Revenue Disclosures -

Note 2 - Revenue Disclosures - Changes in Contract Assets and Contract Liabilities (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018USD ($)
Balance, contract liabilities	$ 11,554
Recognized as revenue during the three months ended March 31, 2018	(483)
Fees received and deferred during the three months ended March 31, 2018	518
Balance, contract liabilities	11,589
Balance, contract assets	2,811
Recognized as cost of revenue during the three months ended March 31, 2018	(126)
Costs incurred and deferred during the three months ended March 31, 2018	260
Balance, contract assets	$ 2,945

Note 2 - Revenue Disclosures 40

Note 2 - Revenue Disclosures - Revenue Related to Performance Obligations (Details) $ in Thousands	Mar. 31, 2018USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-04-01
Revenue expected to be recognized	$ 1,497
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01
Revenue expected to be recognized	1,987
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Revenue expected to be recognized	1,988
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Revenue expected to be recognized	1,863
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue expected to be recognized	1,432
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue expected to be recognized	2,822
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil)
Revenue expected to be recognized	$ 11,589

Note 3 - Restricted Cash - Reco

Note 3 - Restricted Cash - Reconciliation of Cash, Cash Equivalents and Restricted Cash Balance (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 4,033,730	$ 4,216,221	$ 2,676,607
Restricted cash	134,189	103,819	312,551
Total cash, cash equivalents and restricted cash	$ 4,167,919	$ 4,320,040	$ 2,989,158	$ 3,344,258

Note 4 - Notes Receivable (Deta

Note 4 - Notes Receivable (Details Textual) - USD ($)	Oct. 10, 2017	Apr. 29, 2017	Sep. 22, 2017	Aug. 31, 2017	Mar. 31, 2018	Dec. 31, 2017
Company-owned Clinic [Member]
Financing Receivable, Net, Total					$ 482,395	$ 523,785
Regional Developer Territory in Central Florida [Member]
Regional Development Agreement		$ 320,000
Regional Developer Territory in Central Florida [Member] | 10% Interest Bearing Promissory Note Maturing October 1, 2020 [Member]
Financing Receivable, Net, Total		$ 187,000
Notes Receivable, Interest Rate		10.00%
Notes Receivable, Contractual Term		3 years 180 days
Notes Receivable, Principal and Interest, Term		3 years
Regional Developer Territory in Maryland/Washington DC [Member]
Regional Development Agreement				$ 220,000
Regional Developer Territory in Maryland/Washington DC [Member] | 10% Interest Bearing Promissory Note Maturing August 1, 2020 [Member]
Financing Receivable, Net, Total				$ 117,475
Notes Receivable, Interest Rate				10.00%
Notes Receivable, Contractual Term				3 years
Notes Receivable, Principal and Interest, Term				3 years
Regional Developer Territory in Minnesota [Member]
Regional Development Agreement			$ 228,293
Regional Developer Territory in Minnesota [Member] | 10% Interest Bearing Promissory Note Maturing September 1, 2020 [Member]
Financing Receivable, Net, Total			$ 119,147
Notes Receivable, Interest Rate			10.00%
Notes Receivable, Contractual Term			3 years
Notes Receivable, Principal and Interest, Term			3 years
Regional Developer Territories with Texas, Arkansas, and Oklahoma [Member]
Regional Development Agreement	$ 170,000
Regional Developer Territories with Texas, Arkansas, and Oklahoma [Member] | 10% Interest Bearing Promissory Note Maturing October 24, 2020 [Member]
Financing Receivable, Net, Total	$ 135,688
Notes Receivable, Interest Rate	10.00%
Notes Receivable, Contractual Term	3 years
Notes Receivable, Principal and Interest, Term	3 years

Note 5 - Property and Equipme43

Note 5 - Property and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Depreciation, Total	$ 264,353	$ 403,131

Note 5 - Property and Equipme44

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Property and equipment, gross	$ 7,480,811	$ 7,321,803
Accumulated depreciation	(4,192,702)	(3,928,349)
Property and equipment, net	3,719,459	3,800,466
Construction in progress	431,350	407,012
Office Equipment [Member]
Property and equipment, gross	1,170,334	1,137,970
Leasehold Improvements [Member]
Property and equipment, gross	5,162,883	5,117,379
Software Development [Member]
Property and equipment, gross	1,147,594	1,066,454
Property Plant and Equipment, Excluding Construction in Progress [Member]
Property and equipment, net	$ 3,288,109	$ 3,393,454

Note 6 - Fair Value Considera45

Note 6 - Fair Value Consideration (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Financial Instruments, Owned, at Fair Value, Total	$ 0	$ 0

Note 7 - Intangible Assets (Det

Note 7 - Intangible Assets (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Amortization of Intangible Assets, Total	$ 123,064	$ 174,856

Note 7 - Intangible Assets - In

Note 7 - Intangible Assets - Intangible Assets Acquired (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Gross Carrying Amount	$ 3,536,000	$ 3,536,000
Accumulated Amortization	1,899,022	1,775,958
Net Carrying Value	1,636,978	1,760,042
Franchise Rights [Member]
Gross Carrying Amount	1,673,000	1,673,000
Accumulated Amortization	719,757	657,943
Net Carrying Value	953,243	1,015,057
Customer Relationships [Member]
Gross Carrying Amount	701,000	701,000
Accumulated Amortization	694,417	674,667
Net Carrying Value	6,583	26,333
Development Rights [Member]
Gross Carrying Amount	1,162,000	1,162,000
Accumulated Amortization	484,848	443,348
Net Carrying Value	$ 677,152	$ 718,652

Note 7 - Intangible Assets - Es

Note 7 - Intangible Assets - Estimated Amortization Expense (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017
2018 (remainder)	$ 316,525
2,019	413,256
2,020	413,256
2,021	348,034
2,022	133,693
Thereafter	12,214
Total	$ 1,636,978	$ 1,760,042

Note 8 - Debt (Details Textual)

Note 8 - Debt (Details Textual)	Jan. 03, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Mar. 31, 2018USD ($)
Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions		2	12
Revolving Credit Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement	200,000
Line of Credit Facility, Periodic Payment, Interest	$ 25,000
Long-term Line of Credit, Total				$ 1,000,000
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]
Debt Instrument, Face Amount		$ 186,000	$ 800,350
Debt Instrument, Interest Rate, Stated Percentage		4.25%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage			1.50%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage			5.25%

Note 8 - Debt - Maturities of N

Note 8 - Debt - Maturities of Notes Payable (Details)	Mar. 31, 2018USD ($)
2018 (remainder)	$ 100,000
Total	$ 100,000

Note 9 - Equity (Details Textua

Note 9 - Equity (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	60,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 2,885,475
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	60,000		295,286
Allocated Share-based Compensation Expense, Total	$ 139,172	$ 51,038
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 867,997
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 328 days
Restricted Stock [Member]
Allocated Share-based Compensation Expense, Total	$ 68,469	$ 44,027
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 74,772
Minimum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price	$ 4.92
Maximum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price	$ 6.85

Note 9 - Equity - Fair Value As

Note 9 - Equity - Fair Value Assumptions of Options Granted (Details) - Employee Stock Option [Member]	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Expected volatility		42.00%
Expected dividends	0.00%	0.00%
Expected term (years) (Year)	7 years	7 years
Forfeiture rate	20.00%	20.00%
Minimum [Member]
Expected volatility	42.00%
Risk-free rate	2.53%	2.10%
Maximum [Member]
Expected volatility	43.00%
Risk-free rate	2.63%	2.14%

Note 9 - Equity - Stock Options

Note 9 - Equity - Stock Options Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Granted at Market Price, Number of Shares (in shares)	60,000
Employee Stock Option [Member]
Outstanding, Number of Shares (in shares)	1,003,916	953,075
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 4.18	$ 3.66
Outstanding, Weighted Average Fair Value (in dollars per share)	$ 1.93	$ 1.87	$ 1.86
Outstanding, Weighted Average Remaining Contractual Life (Year)	8 years	8 years 36 days	6 years 328 days
Granted at Market Price, Number of Shares (in shares)	60,000	295,286
Granted at Market Price, Weighted Average Exercise Price (in dollars per share)	$ 5.89	$ 4.31
Exercised, Number of Shares (in shares)	(7,500)	(206,875)
Exercised, Weighted Average Exercise Price (in dollars per share)	$ 3.11	$ 1.76
Cancelled, Number of Shares (in shares)	(2,605)	(37,570)
Cancelled, Weighted Average Exercise Price (in dollars per share)	$ 5.03	$ 5.11
Outstanding, Number of Shares (in shares)	1,053,811	1,003,916	953,075
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 4.29	$ 4.18	$ 3.66
Exercisable, Number of Shares (in shares)	476,601
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.77
Exercisable, Weighted Average Fair Value (in dollars per share)	$ 2.07
Exercisable, Weighted Average Remaining Contractual Life (Year)	7 years 219 days

Note 9 - Equity - Restricted St

Note 9 - Equity - Restricted Stock Activity (Details) - Restricted Stock [Member]	3 Months Ended
	Mar. 31, 2018shares
Unvested (in shares)	63,700
Awards granted (in shares)
Awards vested (in shares)
Awards forfeited (in shares)
Unvested (in shares)	63,700

Note 10 - Income Taxes (Details

Note 10 - Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Tax Expense (Benefit), Total	$ (63,355)	$ 40,609

Note 11 - Related Party Trans56

Note 11 - Related Party Transactions (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Shareholder [Member]
Related Party Transaction, Amounts of Transaction	$ 48,000	$ 52,000

Note 12 - Commitments and Con57

Note 12 - Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating Leases, Rent Expense, Net, Total	$ 685,677	$ 744,295

Note 12 - Commitments and Con58

Note 12 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)	Mar. 31, 2018USD ($)
2018 (remainder)	$ 1,904,467
2,019	2,354,982
2,020	2,105,402
2,021	1,991,650
2,022	1,879,686
Thereafter	3,253,292
Total	$ 13,489,479

Note 13 - Segment Reporting (De

Note 13 - Segment Reporting (Details Textual)	3 Months Ended
	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017	Dec. 31, 2016
Number of Operating Segments	2
Number of Stores	406	47	373	61
Corporate Clinics [Member]
Number of Stores	47
Franchise Operations [Member]
Number of Stores	359

Note 13 - Segment Reporting - S

Note 13 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenues	$ 7,098,000	$ 5,507,000
Operating income (loss)	(439,065)	(1,705,311)
Depreciation and amortization	387,417	577,987
Operating income (loss)	(439,065)	(1,705,311)
Other (expense) income, net	(11,194)	(19,465)
Loss before income tax expense	(450,259)	(1,724,776)
Operating Segments [Member]
Operating income (loss)	1,926,000	216,000
Operating income (loss)	1,926,000	216,000
Corporate, Non-Segment [Member]
Operating income (loss)	(2,365,000)	(1,921,000)
Operating income (loss)	(2,365,000)	(1,921,000)
Corporate Clinics [Member]
Revenues	3,257,000	2,497,000
Operating income (loss)	111,000	(1,017,000)
Depreciation and amortization	303,000	444,000
Operating income (loss)	111,000	(1,017,000)
Franchise Operations [Member]
Revenues	3,841,000	3,010,000
Operating income (loss)	1,815,000	1,233,000
Depreciation and amortization
Operating income (loss)	1,815,000	1,233,000
Corporate Segment [Member]
Depreciation and amortization	$ 84,000	$ 134,000

Note 13 - Segment Reporting -61

Note 13 - Segment Reporting - Segment Reporting Information, Assets (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017
Total assets	$ 18,243,252	$ 18,424,559
Unallocated cash and cash equivalents and restricted cash	4,033,730	4,216,221	$ 2,676,607
Unallocated property and equipment	3,719,459	3,800,466
Operating Segments [Member]
Total assets	12,633,000	12,874,000
Unallocated cash and cash equivalents and restricted cash	4,168,000	4,320,000
Unallocated property and equipment	777,000	765,000
Other unallocated assets	665,000	466,000
Corporate Clinics [Member]
Total assets	8,695,000	8,998,000
Franchise Operations [Member]
Total assets	$ 3,938,000	$ 3,876,000

Note 14 - Subsequent Events (De

Note 14 - Subsequent Events (Details Textual)	Apr. 06, 2018USD ($)
Assets and Franchise Agreement [Member] | Subsequent Event [Member]
Business Combination, Consideration Transferred, Total	$ 100,000